Negative results were obtained for cytokeratin 20, CDX2, CD56, S100, and neuroendocrine markers such as synaptophysin, which excluded other tumor types, including neuroendocrine carcinoma and adenocarcinoma (Figure 1G,H). The gene discussed is KRT20; the disease is neuroendocrine carcinoma.